Vitamin E Potentiates the Anti-nociceptive Effects by Intraperitoneal Administration of Lidocaine in Rats
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
The present study was to evaluate effects of vitamin E on intravenous administration of lidocaine-induced antinociception. Experiments were carried out using male Sprague-Dawley rats. Orofacial formalin-induced nociceptive behavioral responses were used as the orofacial animal pain model. Subcutaneous injection of formalin produced significant nociceptive scratching behavior. Intraperitoneal injection of 5 and 10 mg/kg of lidocaine attenuated formalin-induced nociceptive behavior in the 2nd phase, compared to the vehicle-treated group. Intraperitoneal injection of 1 g/kg of vitamin E also attenuated the formalin-induced nociceptive behavior in the 2nd phase, compared to the vehicle-treated group. However, low dose of vitamin E (0.5 g/kg) did not affect the nociceptive behavioral responses produced by subcutaneous injection of formalin. The present study also investigated effects of intraperitoneal injection of both vitamin E and lidocaine on orofacial formalin-induced behavioral responses. Vehicle treatment affected neither formalin-induced behavioral responses nor lidocaineinduced antinociceptive effects. However, intraperitoneal injection of 0.5 g/kg of vitamin E enhanced the lidocaineinduced antinociceptive effects in the 2nd phase compared to the vehicle-treated group. Intraperitoneal injection of naloxone, an opioid receptor antagonist, did not affect antinociception produced by intraperitoneal injections of both vitamin E and lidocaine. These results suggest that treatment with vitamin E enhances the systemic treatment with lidocaine-induced antinociception and reduces side effects when systemically treated with lidocaine. Therefore, the combined treatment with vitamin E and lidocaine is a potential therapeutic for chronic orofacial pain.
Abstract
The present study was to evaluate effects of vitamin E on intravenous administration of lidocaine-induced antinociception. Experiments were carried out using male Sprague-Dawley rats. Orofacial formalin-induced nociceptive behavioral responses were used as the orofacial animal pain model. Subcutaneous injection of formalin produced significant nociceptive scratching behavior. Intraperitoneal injection of 5 and 10 mg/kg of lidocaine attenuated formalin-induced nociceptive behavior in the 2nd phase, compared to the vehicle-treated group. Intraperitoneal injection of 1 g/kg of vitamin E also attenuated the formalin-induced nociceptive behavior in the 2nd phase, compared to the vehicle-treated group. However, low dose of vitamin E (0.5 g/kg) did not affect the nociceptive behavioral responses produced by subcutaneous injection of formalin. The present study also investigated effects of intraperitoneal injection of both vitamin E and lidocaine on orofacial formalin-induced behavioral responses. Vehicle treatment affected neither formalin-induced behavioral responses nor lidocaineinduced antinociceptive effects. However, intraperitoneal injection of 0.5 g/kg of vitamin E enhanced the lidocaineinduced antinociceptive effects in the 2nd phase compared to the vehicle-treated group. Intraperitoneal injection of naloxone, an opioid receptor antagonist, did not affect antinociception produced by intraperitoneal injections of both vitamin E and lidocaine. These results suggest that treatment with vitamin E enhances the systemic treatment with lidocaine-induced antinociception and reduces side effects when systemically treated with lidocaine. Therefore, the combined treatment with vitamin E and lidocaine is a potential therapeutic for chronic orofacial pain.
참고문헌 (40)
- Lauretti GR, "Mechanisms of analgesia of intravenous lidocaine", Rev Bras Anestesiol, 58, pp.280~286 (2008)
- Sheu SS, "Lidocaine's negative inotropic and antiarrhythmic actions. Dependence on shortening of action potential duration and reduction of intracellular sodium activity", Circ Res, 57, pp.578~590 (1985)
- W. A. Catterall, "PHYSIOLOGY: A One-Domain Voltage-Gated Sodium Channel in Bacteria", Science, 294(5550), pp.2306~2308 (2001), American Association for the Advancement of Science (AAAS)[DOI]
- Abram SE, "Systemic lidocaine blocks nerve injury-induced hyperalgesia and nociceptor-driven spinal sensitization in the rat", Anesthesiology, 80, pp.383~391 (1994)
- Araujo MC, "Multiple phases of relief from experimental mechanical allodynia by systemic lidocaine: responses to early and late infusions", Pain, 103, pp.21~29 (2003)
- Finnerup NB, "Intravenous lidocaine relieves spinal cord injury pain: a randomized controlled trial", Anesthesiology, 102, pp.1023~1030 (2005)
- Mao J, "Systemic lidocaine for neuropathic pain relief", Pain, 87, pp.7~17 (2000)
- Woolf CJ, "The systemic administration of local anaesthetics produces a selective depression of C-afferent fibre evoked activity in the spinal cord", Pain, 23, pp.361~374 (1985)
- Leigh White, "Factors preventing kneeling in a group of pre-educated patients post total knee arthroplasty", Journal of Orthopaedics and Traumatology, 17(4), pp.333~338 (2016), Springer Nature[DOI]
- Devor M, "Systemic lidocaine silences ectopic neuroma and DRG discharge without blocking nerve conduction", Pain, 48, pp.261~268 (1992)
- Maret G. Traber, "Vitamins C and E: Beneficial effects from a mechanistic perspective", Free Radical Biology and Medicine, 51(5), pp.1000~1013 (2011), Elsevier BV[DOI]
- Dowd P, "On the mechanism of the anticlotting action of vitamin E quinone", Proc Natl Acad Sci U S A, 92, pp.8171~8175 (1995)
- Claus Schneider, "Chemistry and biology of vitamin E", Molecular Nutrition & Food Research, 49(1), pp.7~30 (2005), Wiley-Blackwell[DOI]
- Azzi A, "Vitamin E : non-antioxidant roles", Prog Lipid Res, 39, pp.231~255 (2000)
- 홍부휘, "흰쥐의 포르말린 유발 통증반응에 미치는 vitamin E의 항통각 효과", Anesthesia and Pain Medicine, 6(1), pp.59~62 (2011), 대한마취통증의학회
- Hee Kee Kim, "Analgesic effect of vitamin E is mediated by reducing central sensitization in neuropathic pain", Pain, 122(1), pp.53~62 (2006), Ovid Technologies (Wolters Kluwer Health)[DOI]
- Abbott FV, "The formalin test : scoring properties of the first and second phases of the pain response in rats", Pain, 60, pp.91~102 (1995)
- Hyo Sun Choi, "Effects of Tnf-α injected intracisternally on the nociceptive jaw-opening reflex and orofacial formalin test in freely moving rats", Progress in Neuro-Psychopharmacology and Biological Psychiatry, 27(4), pp.613~618 (2003), Elsevier BV[DOI]
- Choi HS, "Effects of intracisternal injection of interleukin-6 on nociceptive jaw opening reflex and orofacial formalin test in freely moving rats", Brain Res Bull, 59, pp.365~370 (2003)
- Patrick Raboisson, "The orofacial formalin test", Neuroscience & Biobehavioral Reviews, 28(2), pp.219~226 (2004), Elsevier BV[DOI]
- D.K. Ahn, "Intracisternal administration of chemokines facilitated formalin-induced behavioral responses in the orofacial area of freely moving rats", Brain Research Bulletin, 66(1), pp.50~58 (2005), Elsevier BV[DOI]
- Yang GY, "Intracisternal administration of NR2 antagonists attenuates facial formalin-induced nociceptive behavior in rats", J Orofac Pain, 24, pp.203~211 (2010)
- Tjølsen A, "The formalin test: an evaluation of the method", Pain, 51, pp.5~17 (1992)
- Raboisson P, "Effects of subcutaneous formalin on the activity of trigeminal brain stem nociceptive neurones in the rat", J Neurophysiol, 73, pp.496~505 (1995)
- Leonardo Fernandes Fraceto, "Differential effects of uncharged aminoamide local anesthetics on phospholipid bilayers, as monitored by 1H-NMR measurements", Biophysical Chemistry, 115(1), pp.11~18 (2005), Elsevier BV[DOI]
- Sheets MF, "Molecular action of lidocaine on the voltage sensors of sodium channels", J Gen Physiol, 121, pp.163~175 (2003)
- Charlene Casson, "Implementation and evaluation of a rapid access palliative clinic in a New Zealand cancer centre", Journal of Medical Radiation Sciences, 61(4), pp.217~224 (2014), Wiley-Blackwell[DOI]
- M Hollmann, "Prolonged actions of short-acting drugs: Local anesthetics and chronic pain", Regional Anesthesia and Pain Medicine, 25(4), pp.337~339 (2000), Elsevier BV[DOI]
- Abelson KS, "Intravenously administered lidocaine in therapeutic doses increases the intraspinal release of acetylcholine in rats", Neurosci Lett, 317, pp.93~96 (2002)
- Markus W Hollmann, "Inhibition of m3 muscarinic acetylcholine receptors by local anaesthetics", British Journal of Pharmacology, 133(1), pp.207~216 (2001), Wiley-Blackwell[DOI]
- Biella G, "Central effects of systemic lidocaine mediated by glycine spinal receptors: an iontophoretic study in the rat spinal cord", Brain Res, 603, pp.201~206 (1993)
- Cohen SP, "Is the analgesic effect of systemic lidocaine mediated through opioid receptors?", Acta Anaesthesiol Scand, 47, pp.910~911 (2003)
- Nagy I, "Lignocaine selectively reduces C fibre-evoked neuronal activity in rat spinal cord in vitro by decreasing N-methyl-D-aspartate and neurokinin receptormediated post-synaptic depolarizations; implications for the development of novel centrally acting analgesics", Pain, 64, pp.59~70 (1996)
- Dipak Kumar Sahoo, "Protective effects of vitamin E and curcumin on l-thyroxine-induced rat testicular oxidative stress", Chemico-Biological Interactions, 176(2-3), pp.121~128 (2008), Elsevier BV[DOI]
- Mandava V. Rao, "Protective role of vitamin E on nickel and", or chromium induced oxidative stress in the mouse ovary, 2009, pp.47(6), 1368~1371[DOI]
- Hee Kee Kim, "Reactive oxygen species (ROS) play an important role in a rat model of neuropathic pain", Pain, 111(1), pp.116~124 (2004), Ovid Technologies (Wolters Kluwer Health)[DOI]
- K. Y. Lee, "Involvement of Reactive Oxygen Species in Long-Term Potentiation in the Spinal Cord Dorsal Horn", Journal of Neurophysiology, 103(1), pp.382~391 (2010), American Physiological Society[DOI]
- Eun-Sung Park, "Levels of mitochondrial reactive oxygen species increase in rat neuropathic spinal dorsal horn neurons", Neuroscience Letters, 391(3), pp.108~111 (2006), Elsevier BV[DOI]
- Inhyung Lee, "The role of reactive oxygen species in capsaicin-induced mechanical hyperalgesia and in the activities of dorsal horn neurons", Pain, 133(1), pp.9~17 (2007), Ovid Technologies (Wolters Kluwer Health)[DOI]
- J. Picard, "Guidelines and the adoption of ‘lipid rescue’ therapy for local anaesthetic toxicity", Anaesthesia, 64(2), pp.122~125 (2009), Wiley-Blackwell[DOI]